Introduction
Prediabetes is defined as an intermediate state with plasma glucose levels ranging between normoglycemia and diabetes. The Centers for Disease Control estimated that in 2012 about 86 million, or one out of three, adults had prediabetes in the US. 1 However, 90% of these individuals were unaware of their diagnosis. In 2015, the International Diabetes Federation estimated that the worldwide prevalence of impaired glucose tolerance (IGT) in adults was 318 million and expected to reach 482 million by 2040. 2 The annual progression rate to diabetes is 5-10%, 3 with older individuals, those with severe insulin resistance (IR), low insulin secretion, and other diabetes risk factors even more likely to progress. 4 How can we identify patients with prediabetes and what can we do to prevent progression to diabetes?
Lifestyle and pharmacological interventions have been most effective in preventing progression to diabetes and associated complications. Preservation of βcell function and reduction in IR and diabetes complications such as retinopathy, cardiovascular disease (CVD), and allcause mortality were observed subsequent to lifestyle modifica tion. 5, 6 The Da Qing Diabetes Study in China, 6 the Finnish Diabetes Prevention Study, 7, 8 and the U.S. Diabetes Prevention Program 3, 9 have shown that changes in dietary habits, weight loss, and increased physical activity reduced the risk of progression to diabetes. Bariatric surgery promotes weight loss and is beneficial in prediabetes. 10 
Identification of risk and diagnosis of prediabetes
Development of prediabetes involves multiple factors including genetics, peripheral IR, defects in insulin secretion, glucotoxicity, lipotoxicity, impaired incretin release, Prediabetes is classified as isolated impaired fasting glucose (IFG) or IGT.
14 Glucose and glycated hemoglobin (HbA1c) criteria for diagnosing dysglycemic states are controversial as there are differing thresholds recommended by the American Diabetes Association (ADA) and the World Health Organiza tion. 15 , 16 We will review several additional biomarkers used to predict the risk of progression to diabetes.
Diagnostic biomarkers and their clinical utility Hemoglobin A1c
HbA1c is the most commonly used biomarker to diagnose prediabetes and diabetes. HbA1c forms when glucose attaches to the aminoterminal group of the β subunit of hemoglobin. 17 HbA1c reflects chronic glycemia rather than glucose levels at a single time point. Currently, the ADA criteria for diabetes are HbA1c ≥6.5% (48 mmol/mol) and 5.7-6.4% (39-46 mmol/mol) for prediabetes.
14 Increased HbA1c levels are associated with increased morbidity and mortality. In the Norfolk prospective study, higher HbA1c levels were also associated with increased CVD, cancer, and allcause mortality. 18 Longterm prospective studies, includ ing the Diabetes Control and Complications Trial, the UK Prospective Diabetes Study Group, and the Epidemiology of Diabetes Interventions and Complications study have shown that diabetic complications are directly related to the mean HbA1c, with a level ≥6.5% (48 mmol/mol) associated with retinopathy. [19] [20] [21] Additionally, HbA1c was more strongly cor related with retinopathy than fasting plasma glucose (FPG). Thus, HbA1c may be a better predictor of microvascular complications than FPG. 22 HbA1c has several advantages versus FPG and oral glu cose tolerance test (OGTT) including greater convenience as fasting is not required, greater preanalytical stability, and less daytoday perturbation during periods of stress and ill ness. 23 Since HbA1c reflects chronic exposure to glucose, it is particularly useful for lifestyle modification counseling. 23, 24 However, there is conflicting evidence regarding the useful ness of HbA1c as it provides moderate sensitivity in diabetes diagnosis when compared to OGTT and FPG (Table 1) . 23, 24 OGTT is more strongly correlated with IR and secretion than HbA1c, 25 which is expected since the response to a high dose of glucose would more accurately reflect an individual's physiologic response and insulin secretion and actions. For HbA1c has moderate sensitivity in diagnosing diabetes when compared to OGTT and FPG [24] [25] [26] No consensus which cut-off points for HbA1c would be most sensitive [26] [27] [28] [29] HbA1c threshold for prediabetes does not consider ethnicity, BMi, and age, all of which may significantly alter HbA1c levels 30, 31 HbA1c is not always a reliable measure of average circulating glucose levels 40 Changes in the production rate or circulating 
HDL
A major lipoprotein HDL-C promotes insulin secretion
• Low HDL-C concentration may lead to progression from prediabetes to diabetes
• increased proportion of small HDL3 over HDL-C in subjects with prediabetes 
Ferritin and transferrin
Ferritin is an intracellular protein that stores and releases iron elevated serum ferritin and transferrin saturation have been strongly associated with increased risk of prediabetes and diabetes. iron has properties that contribute to iR such as production of highly active radical formation, damage to DNA and cell membrane integrity, β-cell oxidative stress leading to decreased insulin secretory capacity, and interference with glucose uptake in skeletal muscles and adipocytes. Moreover, catalytic iron stimulates the formation of reactive oxidative species, hepatic dysfunction, and β-cell apoptosis, all of which contribute to iR • Higher prediabetes prevalence
• increased iR
• increased 2-hour glucose
• Adipose inflammation and metabolic dysregulation in obesity and type 2 diabetes 17. GPLD1
GPLD1 has a postulated role in the insulin-mimetic signaling pathway of glycosylphosphatidylinositol compounds, though the exact mechanism is not known GPLD1 cleavage generates second messengers that can act as inulin-mimetic molecules 109 GPLD1 positively associated with:
109
• Type 2 diabetes and prediabetes (less strongly)
• MASP1, another novel prediabetes biomarker
• HDLs in serum
Acylcarnitine
Acyl-carnitines interact with NF-Kβ, which promotes inflammation and IR 
WBCs wBC count is a marker of immunity and inflammation
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NLR is an indicators of subclinical inflammation and microvascular and macrovascular complications in diabetes 142, 143 wBC count has been predictive of:
• worsening insulin action
• Secretory function and T2DM
• Coronary heart disease 
IL-1RA
IL-1RA is an anti-inflammatory marker elevated when iL-1 pathway induced by glucose and free fatty acids during overfeeding 150 Associated with:
• Decreasing insulin sensitivity
• Temporary increasing β-cell function
• elevated in prediabetes and diabetes
151
Abbreviations: HbA1c, hemoglobin A1c; FPG, fasting plasma glucose; BMi, body mass index; FA, fructosamine; GA, glycated albumin; OGTT, oral glucose tolerance test; iR, insulin resistance; 1, 5 AG, 1, 5 anhydroglucitol; FetA, fetuin-A; TLR4, toll-like receptor 4; T2DM, type 2 diabetes mellitus; α-HB, alpha-hydroxybutyrate; α-KB, α-ketobutyrate; L-GPC, L-alpha glycerylphosphorylcholine; Lp(a), lipoprotein(a); HDL-C, high-density lipoprotein cholesterol; HDL-LpPLA 2 , HDL-associated lipoprotein-associated phospholipase A2; MBL, mannose binding lectin; CVD, cardiovascular disease; THBS1, thrombospondin 1; GPLD1, glycosylphosphatidylinositol-specific phospholipase D1; NF-Kβ, nuclear factor-κB; miRNA, microRNA; iFG, impaired fasting glucose; iGT, impaired glucose tolerance; CRP, C-reactive protein; iL, interleukin; wBC, white blood cell; NLR, neutrophillymphocyte ratio; PAi-1, plasminogen activator inhibitor-1; iL-1RA, iL-1 receptor antagonist; SGLT 2 , sodium-glucose co-transporter 2. Moreover, it is not clear which cut points for HbA1c would be most sensitive. Utilizing ADA criteria, HbA1c may miss individuals with prediabetes despite levels <5.5% (37 mmol/ mol). 26 The NHANES and Screening for Impaired Glucose Tolerance studies demonstrated that only 60-70% of subjects had normal glucose tolerance (NGT) when HbA1c levels were <5.7% (39 mmol/mol). [27] [28] [29] In addition, the HbA1c threshold for prediabetes does not consider ethnicity, body mass index (BMI), and age, all of which may significantly alter HbA1c levels. [30] [31] [32] [33] For example, HbA1c levels are higher among African Americans, Hispanics, and Asian/Pacific Islanders compared to nonHispanic whites. One study demonstrated that HbA1c is 0.3% higher in black men and 0.4% higher in black women. 34 As a result, standard classification ranges may misdiagnose some individuals from certain ethnic groups with prediabetes, thus overestimating the prevalence of prediabetes.
HbA1c is not always a reliable measurement of average circulating glucose levels. HbA1c has a life span related to the halflife of the red blood cell ranging from 90 to 120 days. 35 Therefore, changes in the production rate or circulat ing life span of red blood cells will affect HbA1c levels; for example, reduced production leads to a greater percent of older cells, whereas more rapid turnover reduces the average time during which the red cells are exposed to hyperglyce mia. 36 Several clinical conditions may result in overestimation or underestimation of HbA1c levels. Conditions in which HbA1c is falsely elevated include iron deficiency anemia, asplenia, folate and vitamin B12 deficiency, severe hyper triglyceridemia, and uremia. 36 Falsely low HbA1c occurs in hemolytic anemia, blood loss, 37, 38 splenomegaly, and end stage renal disease. 36 Hemoglobin variants, such as HbS, HbC, HbD, and HbE, 39 may also result in overestimation or underestimation of HbA1c, depending on which method is used. 36 For these reasons, HbA1c alone can be inadequate for diagnosing prediabetes, and more accurate diagnosis may require confirmation with other biomarkers. 40 Fructosamine Fructosamine (FA) has been used as an alternate glycemic marker for diabetes screening and may be potentially useful for diagnosing prediabetes. FA is a ketoamine created by glycosylation of total serum proteins, primarily albumin. 41 FA increases in states of high glucose concentrations. Since it reflects average blood glucose concentrations over the previous 1-4 weeks, 38 it can be a useful clinical marker of shortterm glycemic fluctuation and glucose control. 38, 52 FA is especially useful in conditions that affect hemoglobin reli ability, as already described, and has moderate sensitivity and high specificity (Table 1) . 52 Other advantages of FA include costeffectiveness and convenience, as its measurement does not require fasting. 42, 43 Limitations of FA include higher withinsubject variabil ity and falsely low levels when conditions leading to rapid 
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Prediabetes biomarkers albumin turnover are present such as nephrotic syndrome and liver disease. 44 There are conflicting data regarding its efficacy as a biomarker for prediabetes. Several studies found that FA correlates with hyperglycemia and HbA1c levels in both type 1 diabetes mellitus and type 2 diabetes mellitus (T2DM). 41, 45, 46 FA may also indicate the risk for developing microvascular complications. 45 However, not all studies have found that mean serum FA levels are useful for prediabetes screening. 37, 38, 41, [47] [48] [49] Thus, FA could be a valuable complementary marker in clinical conditions where HbA1c may be inaccurate. How ever, as the literature concerning FA is limited, and studies included small or niche patient cohorts, there are insufficient data to conclude its role as an alternate biomarker for micro vascular complications.
Glycated albumin
Similar to FA, glycated albumin (GA) has been found to be a superior index of glycemic control than HbA1c in patients with renal failure, hemolytic anemia, and those receiving blood transfusions. 41, 45 FA refers to all glycated serum pro teins, which includes GA. Therefore, as FA is not corrected for albumin or total protein concentration, FA levels can fluctuate in certain conditions such as liver disease. Alter natively, GA measures the ratio of GA to total albumin. 50 Thus, GA is preferred to FA in clinical conditions that result in protein loss such as nephrotic syndrome, liver, and thyroid disease. 50 While it is unclear whether FA should be corrected for total serum protein concentration, one study described an improvement in the correlation of FA with HbA1c when serum FA was corrected for albumin. 46, 51 Serum GA levels of 15-16% in Asian populations were associated with diabetes. 52, 53 Furthermore, GA has moderate sensitivity and specificity for diagnosing prediabetes and diabetes (Table 1) . However, combining FPG <100 mg/dL (5.56 mmol/L) with serum GA <15% to exclude diabetes, and FPG ≥126 mg/dL (7.0 mmol/L) or serum GA ≥17% to diagnose diabetes, increased the sensitivity of GA. There are no clear threshold values for FA and GA for prediabetes but one study used a level ≥230 μmol/L for FA and ≥13.35% for GA, both of which correlated with HbA1c of 5.7% (39 mmol/mol) for detecting prediabetes. 49 GA as well as FA is associated with CVD, ischemic stroke, retinopathy, chronic kidney disease, and death in the Atherosclerosis Risk in Communities Study. 51, 54 These associations were similar to those of HbA1c, 54 suggesting that FA and GA may be useful alternative biomarkers in clinical conditions where HbA1c is inaccurate. 51 The combination of GA with HbA1c was shown to predict prediabetes with greater sensitivity than HbA1c alone. 49 In addition, GA may be superior to FA for detecting prediabetes, whereas the combination of FA with HbA1c was not superior to HbA1c alone. 47, 49, 50, 55 There are conditions in which GA may be inaccurate due to changes in albumin turnover. For example, the lower GA levels observed in obesity may be due to increased albumin catabolism and decreased rate of albumin synthesis from obesityassociated inflammation. However, the precise mechanism for the lower GA in obesity is unclear. 52, 53, [56] [57] [58] GA may be artificially low in individuals with increased BMI, body fat mass, and visceral adiposity. 53 The mechanism for alterations in GA levels in these conditions is not well understood. 59 1,5 Anhydroglucitol 1,5 Anhydroglucitol (1,5 AG), a dietary monosaccharide, has been suggested as a prediabetes marker. As the proximal tubules in the kidney have a greater affinity for glucose than 1,5 AG, high glucose levels prevent 1,5 AG reabsorption resulting in elevated 1,5 AG urinary excretion. Therefore, plasma 1,5 AG concentrations are inversely correlated with plasma glucose levels 60 demonstrated in a study in which the 1,5 AG level was highest in the control group followed by the prediabetes and diabetes groups, respectively. 60 Some studies, but not all, have found an inverse relationship between 1,5 AG and OGTT 2hour postglucose levels. 61, 62 Studies have also shown an inverse relationship between 1,5 AG and HbA1c as well as FPG levels. 63 Similar to FA, 1,5 AG may be a useful biomarker as it reflects glucose levels within the preceding 10-14 days. 61 1,5 AG is stable, reproducible, and less costly when compared to other glycemic diagnostic tests. 61 It may be useful for identifying postprandial glycemic excursions and individuals at risk of complications as 1,5 AG has been associated with retinopathy and microvascular and macrovascular events in diabetes. However, it is unclear if 1,5 AG is superior to HbA1c. Plasma 1,5 AG levels can change based on diet, sex, 64, 65 and race. Levels are also affected by renal hemody namics or treatment with sodiumglucose cotransporter 2 inhibitors. 66, 67 There is no consensus on the use of 1,5 AG as a prediabetes screening tool. 65, 66 Adiponectin Adiponectin, derived from adipose tissue, exhibits insulin sensitizing, antiinflammatory, and antiatherogenic prop erties and is an independent predictor of diabetes. 68 Lower levels of adiponectin are associated with increased IR and 
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Dorcely et al obesity, while higher levels have been related to lifestyle intervention groups in diabetes prevention trials. 68 The association of adiponectin with diabetes risk appears to be evident at a much earlier stage in the progression to diabetes; more specifically, lower adiponectin levels were observed a decade before diabetes was diagnosed, particularly in men. 68 Additionally, in offspring of parents with T2DM, baseline adiponectin levels are inversely related to the risk of incident prediabetes independent of ethnic or sex differ ences. 69 Using the hyperinsulinemic euglycemic clamp and intravenous glucose tolerance test, adiponectin levels were directly correlated with insulin sensitivity and indirectly with insulin secretion. 69 
Fetuin-A
FetuinA (FetA) is a hepatic secretory glycoprotein that correlates with increased risk of developing T2DM and associated complications. 70 Importantly, unlike adiponectin, the EPICPotsdam prospective cohort study found that FetA was independently associated with T2DM after controlling for BMI and waist circumference. 70 FetA has been proposed to promote lipidinduced IR through the tolllike receptor 4 (TLR4)inflammatory signaling pathway, which results in production of inflammatory cytokines. 71 As chronic inflam mation induced by free fatty acids (FFAs) has been thought to result in IR, the FFATLR4 signaling pathway has been recognized as a cause of IR. However, FFA may not bind directly to TLR4. Pal et al showed that FetA binds to TLR4, and regulates insulin sensitivity through this interaction. 71 Highfat dietfed FetA knockdown mice have less TLR4 mediated inflammatory signaling in adipose tissue and IR, whereas intravenous injection of FetA in this model induced inflammatory signaling and IR. FFAinduced inflammatory cytokine expression in adipocytes occurred only in the pres ence of both FetA and TLR4; removing either prevented FFAinduced IR. FFAs did not produce IR in adipocytes with mutated TLR4 or galactosidecleaved FetA. FetA, TLR4, interleukin (IL)6, and tumor necrosis factor (TNF)α were elevated in obese subjects with diabetes, suggesting an association between lipids, FetA concentrations, and TLR4 expression with IR.
Studies of the association between FetA concentration and CVD have been conflicting. No association, 72 a positive association, 73 or an inverse association have been reported. However one multiethnic US study found a positive trend in those with IFG or diabetes. 74 FetA may be associated with higher risk of CVD in those susceptible to the development of IR. 74 Taken together, these findings suggest that FetA is an endogenous ligand for TLR4 through which lipids induce IR. FetA may therefore serve as a novel therapeutic target for IR.
Metabolites and microRNA Amino acids
Felig et al found that fasting branched chain and aromatic amino acids correlated with obesity and serum insulin, whereas glucose loading decreased amino acid levels in insulinsensitive individuals but not in insulinresistant individuals. 75 This is likely due to insulinmediated inhibi tion of proteolysis by skeletal muscle. More recent studies have demonstrated a correlation between amino acids and prediabetes, IR, and obesity. 76 Branched chain amino acids (BCAAs), isoleucine, leucine, valine, tyrosine, as well as aromatic amino acid phenylalanine and glycine have been significantly associated with diabetes risk. 75, [77] [78] [79] [80] In addition, glutamine, methionine, cysteine, and 2aminoadipic acid are increased in insulinresistant states. [81] [82] [83] By contrast, glycine levels are decreased in individuals with prediabetes. [84] [85] [86] To further support this, a comprehensive systematic review and metaanalysis demonstrated positive associations with BCAAs and aromatic amino acids and inverse associations with glycine and glutamine with risk of T2DM. 85 Alterations in circulating amino acid levels may represent a significant predictive biomarker for IR and T2DM.
α-Hydroxybutyrate αHydroxybutyrate (αHB) is an organic acid byproduct produced during the synthesis of αketobutyrate (αKB), a product of amino acid catabolism (threonine and methionine) and glutathione anabolism (cysteine formation pathway) in hepatic tissue. 76 The formation of αKB is catalyzed by lactate dehydrogenase and αHB. During oxidative stress, the rate of hepatic glutathione synthesis increases, resulting in increased production of αKB. 85, 87 This causes a decrease in the availability of Lcysteine for glutathione synthesis and an elevation in αHB. Thus, in IR, increased oxidative stress and lipid oxidation may cause chronic shifts in gluta thione synthesis leading to elevated αHB levels. 88, 89 This is demonstrated by increased urinary αHB excretion in IR. 90 Using αHB as a biomarker, previous studies were able to distinguish NGTinsulinsensitive (NGTIS) subjects from IGT and IFG subjects and NGTIS subjects from those with NGTIR. Furthermore, using multiple logistic regression analyses, αHB was found to be significantly associated with IR, independent of sex, age, BMI, and collection site. 
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Prediabetes biomarkers and serine, which are upstream of αKB, and an elevation in cysteine. The underlying mechanism may be related to redox imbalance with IR resulting in an increase in αHB. αHB may be an effective biomarker for prediabetes.
76,89
Linoleoyl-glycerophosphocholine
Cholinecontaining phospholipids and sphingomyelins have been associated with increased risk of T2DM. Linoleoyl glycerophosphocholine (LGPC) was investigated in the Relationship Between Insulin Sensitivity and Cardiovascular Disease study. 91 LGPC is formed by hepatic phospholipase A2 and circulatory lecithincholesterol acyltransferase. Phospholipase A2 activity is increased with inflammation.
LGPC may inhibit phospholipase A2 through noncompeti tive enzyme inhibition, thereby exhibiting antiinflammatory properties. 76, 92 Thus, LGPC is a negative predictor of T2DM progression in contrast to αHB, a positive predictor.
76,93
Lipoprotein(a)
Lipoprotein(a) [Lp(a)] is synthesized by the liver. Elevated levels of LP(a) are an independent risk factor for developing CVD. 94 An inverse relationship between serum Lp(a) and the prevalence of prediabetes and T2DM has been reported, although the mechanism for the relationship between serum Lp(a) and T2DM is not clear. 95 Insulin may play a role in reducing Lp(a) levels. 95 
Triglycerides and high-density lipoprotein
Elevated serum triglyceride (Tg) levels have been associated with βcell dysfunction and reduced insulin secretion in prediabetes. 94 Mechanistically, hypertriglyceridemia reduces glucoseinduced insulin secretion through the glucosefatty acid cycle, and promotes βcell apoptosis by stimulating the production of ceramide and nitric oxide. 96 Also, elevated Tg levels can cause lipotoxicity by accumulating within pancreatic β cells. 94, 96 Cholesteryl ester transfer protein mediates the exchange of lipids from Tgrich lipoproteins with highdensity lipo protein (HDL). Increased Tg levels in insulinresistant states accelerate this exchange. 97 Then, the Tg in HDL cholesterol (HDLC) are hydrolyzed by hepatic lipase, resulting in smaller HDLC particles. ATPbinding cassette transporter A (ABCA1) mediates the efflux of cholesterol to small HDL3 particles. 97 Subjects with prediabetes have significantly increased levels of small HDL3 particles compared with HDLC levels. 97 The proportion of small HDL3 particles is positively associated with Tg and negatively associated with HDLC. 97 In contrast to Tg, HDLC promotes insulin secretion through its interaction with ABCA1. Low HDLC concentrations may also lead to progression to diabetes from prediabetes. However, it is unclear if HDLC levels are asso ciated with βcell dysfunction. 96 Lipoproteinassociated phospholipase A 2 (LpPLA 2 ) is an enzyme that degrades oxidatively fragmented phospholipids and may play a role in atherogenesis. 97 Individuals with IFG have significantly decreased HDLassociated LpPLA 2 (HDL LpPLA 2 ) activity compared with subjects with normoglyce mia. Lowdensity lipoproteinassociated LpPLA 2 may exert proinflammatory effects, whereas HDLLpPLA 2 may have an atheroprotective role. 97 Increased levels of small HDL3 particles and decreased activity of the antiatherogenic HDL LpPLA 2 were found in subjects with IFG. 97 Thus, subclasses of HDLC may play a role in the pathogenesis of prediabetes.
Ceramide
In addition to Tg, ceramides have a positive association with prediabetes and T2DM. 85, 98 Ceramides are lipid molecules that mediate IR. 99, 100 Studies have shown that ceramides inhibit insulin action by decreasing phosphorylation and activation of Akt; accumulate in insulinresistant tissues; and induce inflammation through the nuclear factorκB (NFKβ)-TNFα axis. 100, 101 Furthermore, ceramides correlate with coronary artery disease. 102 Additional studies are needed to understand the relation ships between lipid metabolism, prediabetes, and diabetes.
Ferritin and transferrin
Ferritin is an intracellular protein that stores and releases iron. Elevated serum ferritin and transferrin saturation have been strongly associated with increased risk of prediabetes and diabetes. 103, 104 Furthermore, a positive correlation with increased FPG and serum ferritin has been demonstrated. 104 Iron contributes to IR through the production of highly active radical formation, damage to DNA and cell membrane integrity, βcell oxidative stress resulting in decreased insulin secretory capacity, 105 and interference with glucose uptake in skeletal muscles and adipocytes. Moreover, catalytic iron stimulates the formation of reactive oxidative species, hepatic dysfunction, and βcell apoptosis, 105, 106 all of which contrib ute to IR. Dietary iron restriction or chelation prevents the development of diabetes and loss of βcell function. 105 The threshold levels of ferritin that correlate with IR are uncertain as these may vary with sex and age. 107 Additional studies are needed to better understand ferritin and its role in prediabetes. Mannose binding lectinassociated serine proteases are important for innate immune responses and activation of the lectin pathway of the complement system. 108 MASP1, the most abundant serine protease of the complement lectin pathway, has a major role in the complement cascade.
108
MASP1 has been shown to positively correlate with predia betes, diabetes, as well as CVD. One study demonstrated that the onset of prediabetes and IR occurred earlier in those with increased MASP1 plasma levels. 109 There was a positive association with elevated FPG and 2hour glucose levels, but this weakened when adjusted for triacylglycerol levels. This suggests that triacylglycerol may mediate part of the association between MASP1 and HOMAIR. 109 Thrombospondin 1 (THBS1) and glycosylphosphati dylinositolspecific phospholipase D1 (GPLD1) are posi tively associated with prediabetes, whereas apolipoprotein AIV (ApoAIV) is inversely associated.
109 THBS1 is a glycoprotein and member of the THB family, which has numerous functions such as cellular adhesion and migra tion regulation, cytoskeletal organization, cell proliferation and apoptosis, and celltocell interactions. 110 This matrix protein has been found to be associated with increased IR, which may be attributable to THB's inflammatory proper ties, as well as increased 2hour glucose levels and higher prediabetes prevalence. 109 GPLD1, mainly produced in the liver, releases glyco sylphosphatidylinositolanchored membrane proteins. 111 It is associated with serum lipoproteins and has been linked with diabetes and prediabetes. 109, 111 ApoAIV, a component of chylomicrons, very lowdensity lipoprotein and HDL, has been shown to have a significant inverse relationship with prediabetes and diabetes. 109 The exact role of ApoA IV in vivo is unknown aside from regulating appetite and chylomicron production but it may have antioxidant and antiinflammatory properties. 112, 113 There are limited studies describing the relationship between THBS1, GPLD1, and ApoAIV and prediabetes; therefore, more data are required to better understand their respective roles.
Acyl-carnitine
Fatty acid oxidation (FAO) is a major source of cellular energy. 114 Lcarnitine plays a significant role in FAO as it transports activated long chain fatty acids (LCFA) from the cytosol into the mitochondria, a process referred to as the car nitine shuttle. Once inside, fatty acids undergo esterification to CoA. Carnitine palmitoyltransferase 1 exchanges the CoA moiety for carnitine resulting in acylcarnitine production. 115 Recently, serum levels of acylcarnitines have been shown to be elevated in prediabetes. 116, 117 However, the essential role of acylcarnitine in FAO and its mechanism in IR are uncertain. It has been proposed that impairment of FAO and dysregulated mitochondrial function result in accumulation of intermediary products such as acylcarnitines. Thus, there is a mismatch of LCFA delivery and the tricarboxylic acid cycle. 118 Furthermore, acylcarnitines interact with NFKβ, which promotes inflammation and IR. 118 However, there are few studies of acylcarnitines in prediabetes.
MicroRNAs
MicroRNAs (miRNAs) are small, noncoding RNAs involved in posttranscriptional gene expression. These are pertinent to many biological and pathophysiological processes such as growth, development, differentiation, proliferation, and cell death. Recently, miRNAs have been studied in pre diabetes, [119] [120] [121] several of which were increased including miR192 and miR193b. miR192 regulates tumor protein p53, and miR193b is important for the differentiation of brown adipocytes and inflammation reduction. 122 Levels of both miRNAs were elevated in those with IFG and IGT. Furthermore, miR192 and miR193b have been correlated with Tg levels and the fatty liver index in animal models, 120 which may be significant as a fatty liver can be associated with prediabetes. 123 Moreover, exercise was shown to signifi cantly decrease miR192 and miR193b concentrations. 120 Other miRNAs significantly elevated in T2DM include miR9, miR29a, miR30d, miR34a, miR124a2, miR146a, and miR375, all thought to play a role in βcell function. These miRNAs were found to negatively regulate insulin expression, production, or secretion. However, no statistically significant increases were found in subjects with prediabetes, suggesting that there may be reversible pathophysiological processes that occur during prediabetes but not in T2DM. 124 Additional miRNAs are decreased in prediabetes. Circu lating levels of miR126, abundant in endothelial cells play ing a role in endothelial homeostasis and vascular integrity, are decreased in IGT/IFG and T2DM.
125 miR126 levels are increased with diet and exercise. miRNA15a levels were also significantly lower in prediabetes, T2DM, and IFG/ IGT. 119 miR15a is thought to regulate and promote insulin biosynthesis by inhibiting endogenous uncoupling protein2 
355
Prediabetes biomarkers gene expression and increasing insulin secretion. 126 There fore, miR15a has been suggested to play a significant role in βcell function and insulin synthesis.
Inflammatory markers
Prediabetes and IR are characterized by a marked inflamma tory state. [127] [128] [129] Biochemical markers of acutephase reactants and inflammatory cytokines are elevated on the onset of T2DM and may even further increase with disease progres sion. These markers, such as Creactive protein (CRP), white blood cell count, and fibrinogen, have been investigated as potential predictors for the development of T2DM such as in the Atherosclerosis Risk in Communities study. 130 
CRP and iL-6
CRP is the most widely studied inflammatory marker in CVD and its clinical use continues to evolve. CRP is primarily derived from IL6dependent hepatic biosynthesis and is a primary marker of the acute phase response. Many investi gations have demonstrated elevated levels of both IL6 and CRP among individuals with T2DM and IR. In the Women's Health Study, a nationwide cohort of 27,628 women without diabetes mellitus (DM), CVD, or cancer at baseline, 188 women developed DM over a 4year followup period. 131 Median baseline levels of IL6 and CRP were significantly higher among cases than controls. In addition, higher levels of IL6 and CRP were associated with a greater risk of diabetes development. Relative risks of incident T2DM for increas ing quartiles of IL6 were 1.0, 2.5, 4.1, and 7.5, respectively (p<0.001 for trend), and for increasing quartiles of CRP were 1.0, 2.2, 8.7, and 15.7, respectively (p<0.001 for trend). While adjustment for BMI attenuated these relative risks, the results were still positive. These findings were similar when only including women with a baseline HbA1c of 6.0% (42 mmol/mol) or less and after adjustment for fasting insulin levels. This suggests that these inflammatory markers may be useful in identifying individuals at risk of developing T2DM.
The Insulin Resistance Atherosclerosis Study (IRAS) was a multicenter study of 1,625 individuals followed over 5.2 years. 132 Individuals with prediabetes were defined as those developing diabetes during followup. Subjects with prediabetes who were also insulin resistant had elevated CRP levels compared to both insulinsensitive individuals with prediabetes and nondiabetics. These differences were thought partly due to differences in body weight. Since subjects with prediabetes and IR were not hyperglycemic, subclinical inflammation could not be attributed solely to hyperglycemia. This hypothesis was supported in another study demonstrating that the glycemic index was not associ ated with CRP and risk of T2DM, suggesting that hyperglyce mia per se is not the underlying mechanism linking diabetes and inflammation. 133 The association between CRP and prediabetes has been confirmed in other studies. The Gutenberg Health Study was a prospective, observational singlecenter cohort study that included 15,010 adults, 1,425 of whom had prediabetes and 1,299 had diabetes according to HbA1c concentrations. 134 CRP was shown to increase incrementally from normoglyce mia to prediabetes (1.4 vs. 2.3 mg/L), whereas only a small increase was observed between subjects with prediabetes and diabetes (2.3 vs. 2.4 mg/L), suggesting that early immune activation plays a role in the onset of diabetes. Genetic vari ants in the innate immune system and inflammatory cascade also affect CRP and predisposition to T2DM. 128, 135 Other studies have further supported the association between increased levels of CRP and IL6 and prediabe tes. 127, 136 In a metaanalysis evaluating IL6 with the risk for developing T2DM, the overall relative risk was 1.31 (95% confidence interval [CI] 1.17-1.46; p=0.000) per 1 log pg/mL increment in IL6 levels. 137 In another metaanalysis, these authors found that the overall risk of T2DM was 1.26 (95% CI 1.16-1.37; p=0.000) per 1 log mg/L increment in CRP levels. 137 There may be differences in CRP as a predictor of diabetes in women compared to men. 137 Interestingly, the metaanalysis showed that IL6 was more strongly associ ated with T2DM than CRP, questioning the pathogenesis of subclinical inflammation in diabetes. CRP may therefore have a potential downstream role in this process but may not be the precipitating factor. However, in contrast to the latter findings, another study demonstrated that CRP was elevated in obesity and IR, whereas levels were low in insulinsensitive or obese individuals. 138 White blood cell count, fibrinogen, and hematological indices White blood cell count and fibrinogen are also markers of immunity and inflammation that may have clinical relevance for disease progression and organspecific complications in diabetes. Leukocytosis may also predict coronary heart disease. 139 Therefore, the early identification of highrisk individuals may prevent the onset and/or progression of CVD. A high white blood cell count has been shown to predict worsening insulin action, insulin secretory function, and T2DM development in Pima Indians. 140 Fibrinogen may contribute to atherosclerosis by affecting blood viscosity, platelet aggregation, and fibrin formation. Fibrinogen also 
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Dorcely et al modulates coagulation activation and fibrinolysis, and may enhance plaque progression. In the Gutenberg Health Study, fibrinogen levels were higher in prediabetes than in diabetes, although the reason for this finding is not clear. 134 The neutrophillymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) are also indicators of subclini cal inflammation. In a study of 110 adults, subjects were divided into four groups: NGT, IGT, newly diagnosed T2DM, and known T2DM without complications. NLR values were significantly higher in those with prediabetes, newly diagnosed diabetes, and known diabetes compared to the control group. 141 PLR values were significantly lower in the prediabetes and newly diagnosed diabetes groups but higher in subjects with T2DM. Of note, NLR was higher in obese patients with diabetes than in those without diabetes. NLR has also been associated with both microvascular and macrovascular complications in diabetes. [141] [142] [143] [144] Another investigation demonstrated that 1hour postload glucose levels were associated with a significantly higher white blood cell count and fibrinogen. 145 Fiorentino et al showed that individuals with prediabetes had a significant increase in CRP, fibrinogen, and white blood cell count after adjusting for sex, age, smoking, and fasting and 1 and 2hour postload glucose levels. 146 
Plasminogen activator inhibitor-1
Tissue plasminogen activator1 (PAI1) is a marker of reduced fibrinolysis with decreased activity resulting in coagulation abnormalities. 147 Changes in PAI1 levels were shown to be an independent predictor of incident diabetes in IRAS. 148 
iL-18
Through oxidative mechanisms, hyperglycemia acutely increases cytokine concentrations including plasma IL6, as already described, as well as TNFα and IL18. 149 In a prospective casecohort study, subjects with IL18 in the highest quartile had a 70% increased risk of developing T2DM compared to those in the lowest quartile.
149 IL18 also increased with progression from prediabetes to diabetes in the Gutenberg study. 134 
iL-1 receptor antagonist
The IL1 pathway may be induced by glucose and FFAs in the setting of overfeeding and contribute to an inflammatory state. 150 The IL1 receptor antagonist (IL1RA), produced by adipocytes, is an antiinflammatory marker elevated in prediabetes and diabetes, possibly as a reactive response to inflammation. 134 In the Whitehall Study, a casecohort study of 355 individuals with incident T2DM, an increase in IL 1RA in individuals with prediabetes occurred in parallel with decreasing insulin sensitivity, transiently increasing βcell function, and 2hour glucose levels, all of which occurred years before the occurrence of T2DM. 151 Levels of IL1RA were elevated 13 years before the diagnosis of T2DM. Of note, IL1RA increased rapidly 6 years before diagnosis even after adjusting for obesity.
Patient-focused perspectives
According to the Centers for Disease Control and Prevention, as many as 90% of individuals with prediabetes are undi agnosed 1 and therefore fail to receive guidance on lifestyle changes to prevent progression to T2DM. While HbA1c and glucose determinations for screening have been used in clinical practice for many years, each has deficiencies. As previously discussed, since HbA1c is insensitive for diagnos ing acute and intermittent hyperglycemia and can be affected by various medical conditions and ethnicity, identification of other biomarkers would be of immense value. OGTT, while providing important information with regard to risk of devel oping T2DM that HbA1c or FPG do not, is associated with considerable variability, requires fasting, and is invasive and time consuming. However, intermediate time points during the OGTT (e.g., 30 or 60 minute postload values) appear to predict progression to T2DM better than fasting, 2hour post load glucose or HbA1c levels, making this approach more favorable with the possibility of shortening the traditional 2hour test. 152 Additional studies are required to identify the most accurate biomarker(s), recognizing that a single determinant will likely have inherent limitations. Therefore, combining several biomarkers may more precisely predict those at high risk for developing prediabetes and subsequent progression to diabetes.
Conclusion and future perspectives
Categorical or absolute definitions of dysglycemia when applied to a continuous pathophysiologic process may inad vertently underestimate those at risk for progression. Progres sively rising glucose levels, even within the socalled "normal range", occur relatively late in the evolution to T2DM when βcell function may already be reduced. 153 Therefore, a vital need exists to identify more sensitive and precise biomarkers capable of predicting progression to dysglycemic states at the earliest time point when βcell function is still relatively more optimal and may be more responsive to lifestyle modification. Combining biomarkers in a clinical setting may provide bet ter sensitivity and specificity in predicting prediabetes and 
357
Prediabetes biomarkers diabetes. Additional comparison studies of biomarkers will be required to ascertain their clinical utility. Furthermore, genetic studies assessing mutations may provide additional insight into associations with metabolic abnormalities.
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